Iterum Therap Drug Patent Portfolio
Iterum Therap owns 1 orange book drug protected by 4 US patents Given below is the list of Iterum Therap's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11478428 | Combinations of beta-lactam compounds and probenecid and uses thereof | 23 Dec, 2039 | Active |
| US11554112 | Combinations of β-lactam compounds and probenecid and uses thereof | 01 Apr, 2039 | Active |
| US12109197 | Combinations of β-lactam compounds and probenecid and uses thereof | 01 Apr, 2039 | Active |
| US7795243 | Penem prodrugs | 03 Jun, 2029 | Active |
Iterum Therap's Family Patents
Iterum Therap Drug List
Given below is the complete list of Iterum Therap's drugs and the patents protecting them.
1. Orlynvah
Orlynvah is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11478428 | Combinations of beta-lactam compounds and probenecid and uses thereof |
23 Dec, 2039
(14 years from now)
| Active |
| US11554112 | Combinations of β-lactam compounds and probenecid and uses thereof |
01 Apr, 2039
(14 years from now)
| Active |
| US12109197 | Combinations of β-lactam compounds and probenecid and uses thereof |
01 Apr, 2039
(14 years from now)
| Active |
| US7795243 | Penem prodrugs |
03 Jun, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Orlynvah's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List